An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis
Clinical trial NCT03557281 · COMPLETED
Trial details
- NCT number
- NCT03557281
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-22
- Primary completion
- 2021-12-03
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.